Allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with allergic rhinitis who meet the diagnostic criteria; (2) Aged 18-65, male or female; (3) Those who do not take anti allergic drugs within half a month and have informed consent to join the treatment.
Exclusion criteria
Exclusion criteria: (1) Patients who are participating in clinical trials of other drugs for allergic rhinitis; (2) Patients who have participated in clinical trials of other drugs in recent 3 months; (3) Patients with severe nasal septum curvature or polyps; (4) Patients with serious immune, metabolic or other systemic diseases; (5) Patients with malignant tumors; (6) Patients with blood diseases, such as thrombocytopenia or bleeding, are not easy to stop; (7) Pregnant or lactating women; (8) Patients with alcohol or drug abuse; (9) Patients with severe mental disorder or language disorder; (10) Those who cannot sign the informed consent form. (11) Those who must use therapeutic drugs due to other diseases (12) Women with recent family planning.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| metabolomics; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;TNSS;mini-RQLQ;ECP;IL-13; | — |
Countries
China
Contacts
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine